Serotonin reuptake inhibitor formulations

   
   

A process for preparing amorphous paroxetine hydrochloride or sertraline hydrochloride is provided, which comprises preparing a solution in which paroxetine hydrochloride or sertraline hydrochloride and a water-soluble polymer are dissolved in a co-solvent of a volatile organic solvent and water. Said solution is dried to obtain a composition comprising amorphous paroxetine hydrochloride or sertraline hydrochloride and the water-soluble matrix.

Um processo para preparar o hydrochloride amorfo do paroxetine ou o hydrochloride do sertraline é fornecido, que compreendem preparar uma solução em que o hydrochloride do hydrochloride ou do sertraline do paroxetine e um polímero water-soluble são dissolvidos em um co-solvente de um solvente orgânico e de uma água temporários. A solução dita é secada para obter uma composição que compreende o hydrochloride amorfo do hydrochloride ou do sertraline do paroxetine e a matriz water-soluble.

 
Web www.patentalert.com

< Treatment and prevention of cardiovascular events

< Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner

> Structural and cytoskeleton-associated protein

> Methods, systems, and apparatus for monitoring within-day energy balance deviation

~ 00159